SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cepheid (CPHD) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 28/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CPHD
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio7.07
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.67
Book Value / Share$0.00
Revenue / Share$7.49
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2006 |
$-0.50 |
$87.35M |
$-25.99M |
-29.7% |
| 2007 |
$-0.39 |
$129.47M |
$-21.42M |
-16.5% |
| 2008 |
$-0.38 |
$169.63M |
$-21.71M |
-12.8% |
| 2009 |
$-0.39 |
$170.63M |
$-22.5M |
-13.2% |
| 2010 |
$-99.09 |
$212.47M |
$-5.92M |
-2.8% |
| 2011 |
$0.04 |
$277.58M |
$2.63M |
0.9% |
| 2012 |
$-0.30 |
$331.21M |
$-20.04M |
-6.1% |
| 2013 |
$-0.27 |
$401.29M |
$-17.97M |
-4.5% |
| 2014 |
$-0.72 |
$470.14M |
$-50.15M |
-10.7% |
| 2015 |
$-0.67 |
$538.58M |
$-48.53M |
-9% |
